Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
ELASTASE INHIBITOR AND USE THEREOF IN DISEASE TREATMENT
Document Type and Number:
WIPO Patent Application WO/2023/019499
Kind Code:
A1
Abstract:
Disclosed in the present invention are an elastase inhibitor and the use thereof in disease treatment, which belongs to the field of medicines. Specifically, disclosed are a compound of formula (I), a pharmaceutical composition containing the compound of formula (I) and the use thereof in disease treatment. The compound of formula (I) in the present invention has an inhibitory effect on elastase, which can be used for treating or preventing diseases resulting from the effect of elastase, including systemic inflammatory response syndrome (SIRS) with acute lung injury (ALI)/acute respiratory distress syndrome (ARDS).

Inventors:
LI WENHUA (CN)
TIAN SONGCHUAN (CN)
XU HUAN (CN)
LI CHENGYE (CN)
Application Number:
PCT/CN2021/113436
Publication Date:
February 23, 2023
Filing Date:
August 19, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI HUILUN BIOLOGICAL TECH CO LTD (CN)
SHANGHAI HUILUN JIANGSU PHARMACEUTICAL CO LTD (CN)
International Classes:
C07C311/29; A61K31/222; A61P43/00
Foreign References:
EP0347168A11989-12-20
EP0757037A21997-02-05
JP2001048860A2001-02-20
Other References:
IMAKI, KATSUHIRO ET AL: "Non-peptidic inhibitors of human neutrophil elastase: the design and synthesis of sulfonanilide-containing inhibitors", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 4, no. 12, 1 January 1996 (1996-01-01), pages 2115 - 2134, XP002614404
TSONG-LONG HWANG ET AL.: "Synthesis and pharmacological characterization of 2-aminobenzaldehyde oxime analogs as dual inhibitors of neutrophil elastase and proteinase 3.", BIOORGANIC & MEDICINAL CHEMISTRY., vol. 23, no. 5, 16 January 2015 (2015-01-16), XP029199003, DOI: 10.1016/j.bmc.2014.12.056
Attorney, Agent or Firm:
HANGZHOU CRESUN INTELLECTUAL PROPERTY AGENCY CO., LTD. (CN)
Download PDF: